SNY•benzinga•
Reported Saturday, Teva and Sanofi Presented Phase 2b Data At ECCO 2025, Highlighting Duvakitug's Promise For Ulcerative Colitis And Crohn's Disease
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 24, 2025 by benzinga